STAT3 and lip and oral cavity carcinoma: Other studies have highlighted the importance of the JAK/STAT-3 pathway in oral cancer, where malvidin acts as a STAT-3 inhibitor in the SCC13 oral cancer cell line, inhibiting STAT-3 phosphorylation and nuclear translocation, thereby inducing cell cycle arrest and mitochondrial-mediated apoptosis [121].